EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Integrated BioPharma Inc. (INBP) had EBIT Margin of 4.16% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$14.18M |
|
$-0.18M |
|
$12.71M |
|
$1.47M |
|
$13.59M |
|
$0.59M |
|
$0.01M |
|
$0.59M |
|
$0.59M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
$0.59M |
|
$0.92M |
|
30.30M |
|
31.17M |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$18.76M |
|
$1.72M |
|
$6.14M |
|
$24.90M |
|
$4.25M |
|
$0.12M |
|
$0.34M |
|
$4.58M |
|
$20.32M |
|
$20.32M |
|
$20.32M |
|
31.06M |
|
| Cash Flow Statement Financials | |
$2.06M |
|
$-0.20M |
|
$0.08M |
|
$1.68M |
|
$3.62M |
|
$1.94M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.42 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
10.36% |
|
4.16% |
|
|
EBIT Margin |
4.16% |
-- |
|
4.20% |
|
-1.26% |
|
$1.87M |
|
-- |
|
-- |
|
-- |
|
0.57 |
|
1.36 |
|
2.61 |
|
34.48 |
|
-0.88% |
|
-0.88% |
|
-0.71% |
|
-0.87% |
|
$0.65 |
|
$0.06 |
|
$0.07 |
|